EIF2AK3 and Alzheimer disease: Additionally, CHX reversed the activation of the PERK-eIF2α-ATF4-CHOP pathway regulated by AD (Supplementary Fig. S6), suggesting that ATF4 and CHOP may play a pivotal role in AD’s mechanisms.